VERA Q3 2024 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

VERAVera Therapeutics, Inc.

$3B

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$50M

Net Income

-$47M

EPS (Diluted)

$-0.85

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$62M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$369M

Total Liabilities

$80M

Stockholders' Equity

$289M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$50M	-$22M	-128.9%
Net Income	-$47M	-$20M	-132.0%